EPS Plunges to $(0.12) in Q1 for U.S. Physical Therapy, Net Income Halved
USPH is trading near its 52-week low of $58.19 (1.9% above the low).
Summary
U.S. Physical Therapy reported Q1 2026 diluted EPS of $(0.12), a significant decline from $0.80 in the prior year, with net income attributable to shareholders falling by nearly 50% to $5.04 million. This profit decline occurred despite a 7.9% year-over-year revenue increase to $198.3 million, driven by higher patient visits and new hospital alliances. This full earnings disclosure from the 10-Q provides a more complete and concerning picture than the 8-K filed two days prior, which highlighted 'record first-quarter revenue' and a new credit facility but omitted the substantial drop in profitability. The negative EPS is a material new development that could significantly impact the stock, especially as it trades near its 52-week low. Investors will now focus on management's explanation for the profit erosion and the path to improved earnings despite strategic growth initiatives.
At the time of this announcement, USPH was trading at $59.29 on NYSE in the Trade & Services sector, with a market capitalization of approximately $896.6M. The 52-week trading range was $58.19 to $93.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.